Managing the global burden of cardiovascular disease

European Heart Journal, Supplement

Volumn 4, Issue 6, 2002, Pages

  Neal, B ^a,b   Chapman, N ^a   Patel, A ^a  

^a Institute for Health Research   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cardiovascular disease burden; Global

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DEMOGRAPHY; DEVELOPING COUNTRY; EPIDEMIC; HEALTH PROGRAM; HEALTH STATISTICS; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MANAGEMENT; MEDICAL INFORMATION; PRIORITY JOURNAL; RELIABILITY; RISK ASSESSMENT; SOCIOECONOMICS;

EID: 11144322410     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(02)90022-2     Document Type: Conference Paper

References (38)

1. Murray C, Lopez A. The Global Burden of Disease. Cambridge, Harvard University Press, 1996.
2. Murray C, Lopez A. Global patterns of cause of death and burden of disease in 1990, with projections to 2020. In: Investing in Health Research and Development. Report of the Ad Hoc Committee on Health Research Relating to Future Intervention Options. Geneva, World Health Organization, 1996.
3. Yao C, Wu Z, Wu Y. The changing pattern of cardiovascular diseases in China. World Health Stat Q 1993; 46: 113-8.
4. World Bank. World Development Report: Investing in Health. New York, Oxford University Press, 1993.
5. World Health Organization. World Health Statistics Annual. Geneva, World Health Organization, 1995.
6. World Bank. World Development Report 1999/2000: Entering the 21st Century. New York, Oxford University Press, 1999.
7. World Bank. World Urbanization Prospects: The 1999 Revision. New York, Oxford University Press, 1999.
8. Pearson T, Jamison D, Trejo-Gutierrez H. Cardiovascular Disease. New York, Oxford University Press, 1993.
9. Drewnowski A, Popkin B. The nutrition transition: new trends in the global diet. Nutr Rev 1997; 55: 31-43.
10. Beckett L, Rosner B, Roche A, Guo S. Serial changes in blood pressure from adolescence into adulthood. Am J Epidemiol 1992; 135: 1166-77.
11. Van Rooyen J, Kruger H, Huisman H, et al. An epidemiological study of hypertension and its determinants in a population in transition: the THUSA study. J Hum Hypertens 2000; 14: 779-87.
12. Hakeem R, Thomas J, Badruddin S. Urbanisation and coronary heart disease risk factors in South Asian children. J Pak Med Assoc 2001; 51: 22-8.
13. Hakeem R, Thomas J, Badruddin S. Rural-urban differences in food and nutrient intake of Pakistani children. J Pak Med Assoc 1999; 49: 288-94.
14. Taylor R, Jalaludin B, Levy S, Montaville B, Gee K, Sladden T. Prevalence of diabetes, hypertension and obesity at different levels of urbanisation in Vanuatu. Med J Aust 1991; 155: 86-90.
15. Yach D, Bettcher D. Globalisation of tobacco industry influence and new global responses. Tob Control 2000; 9: 206-16.
16. World Health Organization. Tobacco or Health: a Global Status Report. Geneva, World Health Organization, 1997.
17. The WHO Monica Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. World Health Stat Q 1988; 41: 115-39.
18. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995; 346: 1647-53.
19. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol and stroke in eastern Asia. Lancet 1998; 352: 1801-7.
20. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994; 309: 901-11.
21. Chen Z-M, Xu Z, Collins R, Li W-X, Peto R. Early health effects of the emerging tobacco epidemic in China: A 16-year prospective study. JAMA 1997; 278: 1500-4.
22. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialised countries since 1950. World Health Stat Q 1998; 41: 155-68.
23. Lopez A. Assessing the burden of mortality from cardiovascular disease. World Health Stat Q 1993; 46: 91-6.
24. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
25. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994; 50: 272-98.
26. ISIS Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988: 349-60.
27. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists and other blood pressure lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000; 356: 1955-64.
28. Ad Hoc Committee on Health Research Relating to Future Intervention Options. Investing in Health Research and Development. Geneva, World Health Organization, 1996.
29. Institute of Medicine Board on International Health. Control of Cardiovascular Diseases in Developing Countries. Washington, DC, National Academy Press, 1997.
30. Wu Z, Yao C, Zhao D, et al. Multiprovincial monitoring of the trends and determinants in cardiovascular diseases (Sino-Monica project): morbidity and mortality monitoring. Chin J Cardiol 1997; 25: 6-11.
31. Jackson R, Barham P, Bills J, et al. Management of raised blood pressure in New Zealand: a discussion document. BMJ 1993; 307: 107-10.
32. Guidelines Subcommittee. 1999 World Health Organization - International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-83.
33. Tudor-Smith C, Nutbeam D, Moore L, Catford J. Effects of the Heartbeat Wales programme over five years on behavioral risks for cardiovascular disease: quasi-experimental comparison of results from Wales and a matched reference area. BMJ 1998; 316: 818-22.
34. Puska P. The North Karelia Project: nearly 20 years of successful prevention of CVD in Finland. Hygie 1992; 11: 33-5.
35. Farquhar J, Fortmann S, Flora J, et al. Effects of community wide education of cardiovascular risk factors: the Stanford five-city project. JAMA 1990; 264: 359-65.
36. Luepker R, Murray D, Jacobs D, et al. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota heart health program. JAMA 1994; 84: 1383-93.
37. Carleton R, Lasater T, Assaf A, Feldman H, McKinlay S, for the Pawtucket Heart Health Program Writing Group. The Pawtucket Heart Health Program: community changes in cardiovascular risk factors and projected disease risk. Am J Public Health 1995; 85: 777-85.
38. Mullen P, Mains D, Velez R. A meta-analysis of controlled trials of cardiac education. Patient Educ Couns 1992; 19: 143-62.